Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent Panitumumab
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Head and Neck Cancer
Related studies linked through entity extraction aliases.
Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Accelerated Fractionation Radiotherapy (AFRT) Versus Concurrent Chemoradiotherapy (Crt) In Locally Advanced Head And Neck Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Pilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of Head and Neck
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of the Combination of Panitumumab With Paclitaxel as First-line Treatment of Subjects With Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer
- Status
- UNKNOWN
- Phase
- NA
Comprehensive Assessment of Head and Neck Cancer Survivors
- Status
- COMPLETED
- Phase
- N/A
Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Symptom Burden in Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Evaluation of the New Hypoxia Imaging Agent HX4
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Quality-Of-Life Assessment in Patients With Head and Neck Cancer Treated With Radiation Therapy
- Status
- UNKNOWN
- Phase
- N/A
Biomarkers of Response in Blood and Tumor Tissue Samples From Patients With Unresectable Stage IV Squamous Cell Cancer of the Head and Neck Previously Treated With Cetuximab, Cisplatin, and Radiation Therapy
- Status
- COMPLETED
- Phase
- N/A
Biomakers in Tissue Samples From Patients With Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck Previously Treated With Cisplatin With or Without Cetuximab
- Status
- COMPLETED
- Phase
- N/A
Organ Preservation in the Multispeciality Therapy of Stage II-IV Locally Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- N/A
Trial of Induction Chemotherapy With Carboplatin and Paclitaxel, Followed by Concurrent Chemotherapy/Radiation Therapy With ZD1839 (IRESSA), 5-FU, Hydroxyurea, and Twice-Daily Radiation, Followed by Adjuvant ZD1839 Monotherapy in Patients With Locally Advanced Head & Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of 250-mg ZD1839 Monotherapy in Recurrent or Metastatic or Both Recurrent and Metastatic Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Lapatinib and Cetuximab in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1